Abstract
Lateral internal sphincterotomy (LIS) remains the gold standard surgical approach for the management of chronic anal fissures (CAF). The procedure, however, is complicated by the risk of postoperative incontinence. In recent years, intrasphincteric botulinum toxin (BT) has gained popularity as an alternative approach, despite being inferior to LIS with regard to cure rates. In the real world, patients at high risk for postoperative incontinence are likely to be offered BT as a preliminary procedure. The aim of this study was to explore the real-world outcomes of LIS and BT for a cohort of CAF patients.